About: http://webisa.webdatacommons.org/130302002

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	Number of Participants With Treatment Related Adverse Events of Somatropin: <65 Years of Age vs. >=65 Years of Age. [ Time Frame: 6 month ] [ Designated as safety issue: Yes ]To determine whether age is a significant risk factor in the frequency of treatment related adverse events.
http://www.w3.org/ns/prov#wasQuotedFrom	clinicaltrials.gov